STOCKSCOUTER
StockScouter Premium
StockScouter Screener and Portfolios are now in our premium offering.
Learn more or Get it now! Stockscouter Portfolio performance
Learn more or Get it now! Stockscouter Portfolio performance
CHRS COHERUS BIOSCIENCES INCORPORATED StockScouter® Report
1
StockScouter® Score
COHERUS BIOSCIENCES INCORPORATED, a small cap value company in the healthcare sector, is expected to underperform the market over the next six months with higher than average risk
10 is the best possible rating. Learn more.
Summary
Positives
- Earnings growth in the past year is holding steady compared to earnings growth in the past three years. Neutral
Concerns
- The most recent quarterly earnings report was significantly lower than analysts’ consensus forecast. Negative
- One or more analysts has significantly decreased quarterly earnings estimates for CHRS. Negative
- Moving average analysis for CHRS suggests weak price movement over the medium term. Negative
Short-term Outlook
Over the next 1-2 months, StockScouter forecasts that small cap stocks will be out of favor, value stocks will be out of favor, and healthcare stocks will be out of favor.
Expected Risk/Return
Core Model Grades
D
C
C
F